Google
×
The company's diverse business lines offer its global customers a wide range of coverage sold primarily through independent agents and brokers.
Investors · Contact Us · Travelers Logo Investor Relations · Financial Information · Quarterly Results · SEC Filings · Annual Reports · Statutory Statements ...
People also ask
The company has three investigational drug candidates, including TRV250 for the acute treatment of migraine and TRV734 for maintenance treatment of opioid use ...
Investor Presentation – September 2022. Page 2. LONG-TERM FINANCIAL STRATEGY. CREATE SHAREHOLDER VALUE. Objective: Mid–Teens Core ROE Over Time. Balanced.
9 hours ago · The Travelers Companies, Inc. (TRV) Q1 2024 Earnings Call Transcript · Abbe Goldstein - SVP, IR Alan Schnitzer - Chairman & CEO · David Motemaden ...
10 hours ago · The Zacks Consensus Estimate was pegged at 93. Segment income of $764 million increased 1.1% year over year on higher net investment income. The ...
Discover real-time The Travelers Companies, Inc. Common Stock (TRV) stock prices, quotes, historical data, news, and Insights for informed trading and ...
Jan 23, 2024 · Our presentation today includes forward-looking statements. The company cautions investors that any forward-looking statement involves risks and ...
Jul 23, 2023 · Our presentation today includes forward-looking statements. The company cautions investors that any forward-looking statement involves risks and ...
10 hours ago · Get our analysts' objective, in-depth, and continuous investment coverage of TRV so you can make buy / sell decisions free of market noise.